SABSW Latest News, Press Relases and Analysis

All

Press Releases

12 days ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

12 days ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Third Quarter Financial Results and Recent Business Highlights

22 days ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

22 days ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Present Data at the International Society for Pediatric and Adolescent Diabetes Annual Conference Showcasing Progress in the Development of SAB-142

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Appoints Lucy To as Chief Financial Officer

22 days ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Participate in Upcoming Investor Conferences

2 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Highlights Data in Multiple Presentations at EASD

2 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Highlights Data in Multiple Presentations at EASD

3 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

3 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

4 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

4 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

4 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Oversubscribed $175 Million Private Placement

4 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Oversubscribed $175 Million Private Placement

7 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

7 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Q1 2025 Financial Results and Provides Company Updates

8 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Full Year 2024 Operating and Financial Results

8 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Reports Full Year 2024 Operating and Financial Results

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Participate in Upcoming Investor Conferences

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Participate in Upcoming Investor Conferences

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Positive Topline Phase 1 Clinical Results with Potentially Disease-Modifying T1D Therapy SAB-142

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

10 months ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces R&D Webinar Event to Review Phase 1 Topline Results for SAB-142, a Disease-Modifying T1D Therapy

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAb Biotherapeutics Rebrands as SAB BIO

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAb Biotherapeutics Rebrands as SAB BIO

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIO Appoints Lucy To as Chief Financial Officer

a year ago - By: SAB Biotherapeutics, Inc. - Mentions: SABS

SAB BIOTHERAPEUTICS INC-W (SABSW) Stock News

SABSW Latest News, Press Relases and Analysis